Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

14/02/2019 01:30

Feb 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2018        Dec 31, 2017       Mar 31, 2019  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales                                                  200 mln     
                                                       (+33.3 pct)   
  Operating     loss 424 mln                           loss 682 mln  
  Recurring     loss 501 mln                           loss 739 mln  
  Net           loss 503 mln                           loss 741 mln  
  EPS          loss 131.63 yen                       loss 188.31 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T